Amino-terminal pro–brain natriuretic peptide concentrations are lower in overweight and obese patients, but maintain diagnostic and prognostic capacity in acute dyspnea.
Does body mass index affect the diagnostic and prognostic usefulness of NT-proBNP in patients with acute dyspnea?
NT-proBNP retains its diagnostic and prognostic utility in patients with acute dyspnea across all BMI categories, despite absolute levels being lower in overweight and obese individuals.
Absolute Event Rate: 0% vs 0%
In patients with and without acute heart failure, the NT-proBNP concentrations are relatively lower in overweight and obese patients with acute dyspnea. Despite this, the NT-proBNP concentration retains its diagnostic and prognostic capacity across all BMI categories.
Antoni Bayés‐Genís (Mon,) reported a other. Amino-terminal pro–brain natriuretic peptide concentrations are lower in overweight and obese patients, but maintain diagnostic and prognostic capacity in acute dyspnea.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: